Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

被引：0
|
作者：
Yang, Lihua
Ma, Xiaoli
Liu, Yu-Chen
Zhao, Wen
Yu, Lihua
Qin, Maoquan
Zhu, Guanghua
Wang, Kai
Shi, Xiaodong
Zhang, Zhaoxia
Wang, Jingfu
Sun, Yuan
Dong, Lujia
Tsao, Shih-Ting
Zhang, Rui
Chang, Lung-Ji
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3335
引用
收藏
页数：2
相关论文
共 42 条
  • [1] Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China
    Dong, Lujia
    Chang, Lung-Ji
    Gao, Zhiyong
    Lu, Dao-Pei
    Zhang, Jian-Ping
    Wang, Jing-Bo
    Zhang, Le-Ping
    Chen, Yu-Hong
    Zheng, Hu-Yong
    Liu, Ting
    Niu, Ting
    Huang, He
    Liu, Rong
    Wang, Heng-Xiang
    Gao, Li
    Yang, Tong-Hua
    Lai, Xun
    BLOOD, 2015, 126 (23)
  • [2] Phase I/II Trial of Multi Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 13 - 14
  • [3] Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors
    Zhao, W.
    Dong, L.
    Wang, H.
    Zheng, X.
    Zhang, C.
    Wang, K.
    Zhu, G.
    Wang, B.
    Qin, M.
    Liu, Y.
    Zhang, D.
    Jin, M.
    Zheng, H.
    Zhang, L.
    Ma, X.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S38 - S38
  • [4] Enhanced anti-tumor activity mediated by combination chimeric antigen receptor T cells targeting GD2 and GPC2 in high-risk neuroblastoma
    Wu, Huantong
    Zhang, Guangji
    Liu, Zhongfeng
    Liu, Weihua
    Wang, Xuan
    Zhao, Yu
    CYTOTHERAPY, 2024, 26 (11) : 1308 - 1319
  • [5] Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas
    Chang, Lung-Ji
    Li, Yuhua
    Tu, Sanfang
    Lai, Xun
    Huang, Rui
    Tsao, Shih-Ting
    Liu, Yu-Chen
    Zhang, Rui
    Deng, Lan
    Zhou, Xuan
    Zhang, Hongyu
    Zhang, Wenli
    Li, Yuchen
    BLOOD, 2018, 132
  • [6] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Lihua Yu
    Lulu Huang
    Danna Lin
    Xiaorong Lai
    Li Wu
    Xu Liao
    Jiale Liu
    Yinghua Zeng
    Lichan Liang
    Guanmei Zhang
    Bin Wang
    Zhu Wu
    Shaohua Tao
    Yuchen Liu
    Cheng Jiao
    Lung-Ji Chang
    Lihua Yang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2643 - 2652
  • [7] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Yu, Lihua
    Huang, Lulu
    Lin, Danna
    Lai, Xiaorong
    Wu, Li
    Liao, Xu
    Liu, Jiale
    Zeng, Yinghua
    Liang, Lichan
    Zhang, Guanmei
    Wang, Bin
    Wu, Zhu
    Tao, Shaohua
    Liu, Yuchen
    Jiao, Cheng
    Chang, Lung-Ji
    Yang, Lihua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2643 - 2652
  • [8] eNovel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma
    Chulanetra, Monrat
    Sayour, Elias
    Eldjerou, Lamis
    Lagmay, Joanne
    Milner, Rowan
    Slayton, William
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [9] Academic, Phase I/II Trial on T Cells Expressing a Third-Generation GD2 Chimeric Antigen Receptor and Inducible Caspase-9 Safety Switch for Treatment of Relapsed/Refractory High-Risk Neuroblastoma
    Del Bufalo, F.
    Del Baldo, G.
    Mastronuzzi, A.
    Serra, A.
    De Ioris, M. A.
    Castellano, A.
    Caruana, I.
    Bertaina, V.
    Sinibaldi, M.
    Di Cecca, S.
    DeAngelis, B.
    Garganese, M. C.
    Merli, P.
    Pira, G. Li
    Pagliara, D.
    Leone, G.
    Quintarelli, C.
    Locatelli, F.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S53 - S54
  • [10] Sequential GD2 Chimeric Antigen Receptor T Cell Therapy (4SCAR2.0-GD2) for the Treatment of Refractory/Relapsed Neuroblastoma
    Liu, Yuchen
    Wang, Jingfu
    Kang, Suyi
    Zhang, Rui
    Chang, Lung-Ji
    BLOOD, 2022, 140 : 7462 - 7463
12345